| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1970780 | Clinical Biochemistry | 2006 | 9 Pages |
Abstract
The MEIA demonstrated acceptable analytical characteristics for use for routine monitoring of sirolimus immunosuppressive therapy, and is a viable alternative to HPLC-based methods for sirolimus monitoring.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
D. Wilson, F. Johnston, D. Holt, M. Moreton, J. Engelmayer, J.-M. Gaulier, H. Luthe, P. Marquet, D. Moscato, M. Oellerich, R. Mosso, F. Streit, M. Brunet, C. Fillee, R. Schmid, P. Wallemacq, G. Barnes,